| [1] | Lee H., Kim B., Park J., et al. (2025). Cancer stem cells: Landscape, challenges and emerging therapeutic innovations. Signal Transduct. Target. Ther.10:248. DOI:10.1038/s41392-025-02360-2 |
| [2] | Pan Y., Yuan C., Zeng C., et al. (2025). Cancer stem cells and niches: Challenges in immunotherapy resistance. Mol. Cancer 24:52. DOI:10.1186/s12943-025-02265-2 |
| [3] | Liu H., Dong A., Rasteh A. M., et al. (2024). Identification of the novel exhausted T cell CD8 + markers in breast cancer. Sci. Rep. 14:19142. DOI:10.1038/s41598-024-70184-1 |
| [4] | Bhandarkar V., Dinter T. and Spranger S. (2025). Architects of immunity: How dendritic cells shape CD8(+) T cell fate in cancer. Sci. Immunol. 10:eadf4726. DOI:10.1126/sciimmunol.adf4726 |
| Liu H. (2026). Tumor immune stemness at the interface of cancer plasticity and immune evasion. The Innovation Oncology 1:100003. https://doi.org/10.59717/j.xinn-oncol.2026.100003 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Tumor immune stemness as a dynamic functional state